Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-18

Clinical Trial Update: A Trial to Study BAY1753011 in Patients With Congestive Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 trial investigating BAY1753011 in patients with congestive heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BAY1753011

Snippet

Sponsor: Bayer | Conditions: Heart Failure (HF) | Phase 2 | Status: COMPLETED